Clinical Trials on Multiple Osteochondroma in France

Total 1081 results

University Hospital, Toulouse
MedSharing

Recruiting

A Pilot Study of the Efficacy and Safety of Dupilumab Versus Placebo in Patients With Netherton Syndrome (NS-DUPI)

Netherton Syndrome

France
Centre Hospitalier Universitaire de Nīmes

Completed

Validation of Self-administered Questionnaire for Assessing Calcium Intake in Patients With Multiple Sclerosis or Chronic Inflammatory Arthritis (QALCIMUM)

Multiple Sclerosis | Rheumatoid Arthritis

France
Institut Paoli-Calmettes

Completed

Economic Evaluation of the Use of Plerixafor for Autologous HSC Transplantation for Multiple Myeloma (PLERIXAFOR)

Multiple Myeloma

France
Cartesian Therapeutics

Terminated

Descartes-08 Consolidation Treatment in Patients With High-Risk Multiple Myeloma High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy

Myeloma Multiple

United States
Lille Catholic University

Terminated

A Reeducation Program to Effort to Improve the Walking of Multiple Sclerosis Patients (AEROSEP)

Multiple Sclerosis

France
Hospices Civils de Lyon

Completed

Vaccine Exposure in Patients With MS (Enquête Vaccin)

Multiple Sclerosis

France
Hospices Civils de Lyon

Not yet recruiting

The Aim is to Identify Recurrent Genomic Mutations and/or Predisposing Polymorphisms in Patients With Sporadic Cases of Multiple Myeloma (MMSPORADGEN)

Multiple Myeloma

France
Nantes University Hospital

Completed

Safety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06) (IFM2013-06)

Newly Diagnosed Multiple Myeloma

France
Hospices Civils de Lyon

Recruiting

Smith Magenis Syndrome and Autism Spectrum Disorders (SMS/TSA)

Autism Spectrum Disorder | Smith-Magenis Syndrome

France
Pierre and Marie Curie University

Completed

Symptoms and Treatment Assessment of Ano-Rectal Disorders in Multiple Sclerosis Patients : STAR-Q (STAR-Q)

Multiple Sclerosis | Constipation | Fecal Incontinence

France
Assistance Publique - Hôpitaux de Paris

Completed

Natural History of Asphyxiating Thoracic Dystrophy (DTJ) (DTJ)

Asphyxiating Thoracic Dystrophy

France
Centre Hospitalier Universitaire, Amiens
University Hospital, Rouen; University Hospital, Caen

Recruiting

Physical Activity for Myeloma Autograft Longitudinal Study (PAMAL)

Quality of Life | Physical Activity | Multiple Myeloma

France
University Hospital, Toulouse

Recruiting

Register of Patients With Prader-Willi Syndrome

Prader-Willi Syndrome

France
University Hospital, Toulouse

Completed

Oxytocin Intranasal Administrations in Children With Prader-Willi Syndrome Aged From 3 to 12 Years (Oxyjeune)

Prader-Willi Syndrome

France
University Hospital, Toulouse

Completed

Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome (PRADOTIM)

Prader-Willi Syndrome

France
Institut Jerome Lejeune
Fondation Jérôme Lejeune

Completed

Pilot Study of Auto-immune Abnormalities Associated With Down Syndrome (IMMUTRI)

Down Syndrome With and Without Auto Immune Abnormalities

France
University Hospital, Toulouse
Institut Claudius Regaud

Recruiting

Impact of Chemotherapeutic Treatments in Patients Aged 75 Years and Over Treated for Lymphoid Hematological Malignancy (LYMPHOLD)

Lymphoma | Neoplasm, Plasma Cell

France
Assistance Publique - Hôpitaux de Paris
INSERM UMR 1163

Not yet recruiting

Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory Hemopathies (GEN-HEMO-INF)

Multiple Myeloma | Waldenstrom Macroglobulinemia | Monoclonal Gammopathy of Undetermined Significance

France
Centre Hospitalier Universitaire de Nice

Completed

COVID-19 on Disease Activity in Radiologically Isolated Syndrome Cohort (VaxiRIS)

COVID-19 | Multiple Sclerosis

France
Assistance Publique - Hôpitaux de Paris
IPSEN pharmaceutical company, Boulogne-Billancourt, France

Completed

Lanreotide In Polycystic Kidney Disease Study (LIPS)

Autosomal Dominant Polycystic Kidney Disease (ADPKD

France
Poitiers University Hospital

Completed

Pharmacokinetics of Lenalidomide (Revlimid®) in Patients With Multiple Myeloma and Impaired Renal Function

Multiple Myeloma | Impaired Renal Function

France
Janssen Research & Development, LLC

Completed

A Dose Escalation Study of the Histone Deacetylase Inhibitor (HDACi) JNJ 26481585 in Combination With VELCADE (Bortezomib) and Dexamethasone for Patients With Relapsed Multiple Myeloma

Multiple Myeloma

France
Centre Hospitalier Universitaire, Amiens

Completed

Value of Macrophage-Colony Stimulating Factor as a New Marker of Bone Lesions in Multiple Myeloma (MCSF-MYELOME)

Multiple Myeloma

France
University Hospital, Bordeaux
Ministry of Health, France

Completed

Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis (PROMESS)

Multiple Sclerosis, Chronic Progressive

France
Biogen

Completed

A Study Evaluating the Effectiveness of Tecfidera (Dimethyl Fumarate) on Multiple Sclerosis (MS) Disease Activity and Patient-Reported Outcomes (PROTEC)

Multiple Sclerosis | Relapsing-Remitting Multiple Sclerosis

France, Italy, Spain, Czechia, Hungary, Austria, Belgium, Canada, Portugal, Slovakia, Slovenia
Laboratoires Vivacy

Recruiting

Study of a Novel Hyaluronic Acid Based Gel for Volume Deficiency in the Mid-face (FaceHyal) (FaceHyal)

Aging | Aesthetics | Volume Deficiency in the Mid-Face

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Prospective Evaluation of the Prognostic Impact of Measurable Residual Disease (MRD) Within a Phase III Study Comparing a Fixed Duration Therapy Versus Continuous Therapy With Daratumumab, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma Requiring a First Salvage Treatment. (MRD-CONFIRM)

Multiple Myeloma

France
University Hospital, Bordeaux

Recruiting

Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants. (GENEPI)

Rubinstein-Taybi Syndrome

France
Centre Hospitalier Universitaire, Amiens

Withdrawn

Rationale for Cytogenetic Risk Stratification by Imaging Flow Cytometry in Multiple Myeloma (CIF-PM)

Multiple Myeloma

France
Assistance Publique - Hôpitaux de Paris

Completed

T21,18 and 13 Screening by Cell Free Fetal DNA in Low Risk Patients (DEPOSA)

Trisomy 21, 18 and 13 Screening

France
Assistance Publique - Hôpitaux de Paris

Unknown

Prenatal Screening for Imprinting Anomalies Implicated in Beckwith Wiedemann and Silver Russell Syndromes (DASIRUWIBE)

Pregnant Women Requiring Amniocentesis

France
Biogen
AbbVie

Completed

Efficacy and Safety of BIIB019 (Daclizumab High Yield Process) Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple Sclerosis ((DECIDE))

Relapsing-Remitting Multiple Sclerosis

Sweden, United States, Brazil, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Ukraine, Denmark, Finland, Romania, Canada, France, Hungary, Israel, Switzerland, Serbia, India, Mexico, Poland, Georgia, Ireland, Argentin... and more
Hoffmann-La Roche
PPD

Recruiting

A Study To Evaluate Safety And Efficacy Of Ocrelizumab In Comparison With Fingolimod In Children And Adolescents With Relapsing-Remitting Multiple Sclerosis (Operetta 2)

Relapsing-Remitting Multiple Sclerosis

United States, Belgium, Canada, Spain, India, Italy, Mexico, Portugal, Argentina, Austria, Brazil, United Kingdom, Germany, Netherlands, Serbia, Australia, Bulgaria, France, Greece, Hungary, Poland, Ukraine, Estonia, Denmark, Croatia, Latvia and more
Ad scientiam

Completed

Digitalization of Neurofunctional Tests Via a Mobile Application DAMS for Multiple Sclerosis Patients (MSCopilot)

Multiple Sclerosis

France
EMD Serono Research & Development Institute, Inc.

Completed

CLARITY Extension Study

Relapsing-Remitting Multiple Sclerosis

Croatia, United States, Bulgaria, France, Italy, Russian Federation, Turkey, United Kingdom, Estonia, Germany, Latvia, Lithuania, Poland, Austria, Brazil, Canada, Finland, Portugal, Greece, Serbia, Denmark, Ukraine, Saudi Arabia, Lebanon and more
University Hospital, Montpellier
Association Française contre les Myopathies Telethon

Completed

Exploiting Epigenome Editing in Kabuki Syndrome: a New Route Towards Gene Therapy for Rare Genetic Disorders (Epi-KAB)

Kabuki Syndrome 1

France
University Hospital, Clermont-Ferrand
Laboratoires Takeda

Unknown

Neurotoxic Effect of Bortezomib Treatment in Patient With Myeloma Multiple (SENSIB)

Multiple Myeloma | Adult | Bortezomib Regimen

France
Biogen
Elan Pharmaceuticals

Terminated

Study Evaluating Rebif, Copaxone, and Tysabri for Active Multiple Sclerosis (SURPASS)

Relapsing Remitting Multiple Sclerosis

United States, Czech Republic, Italy, Spain, Sweden, Latvia, Finland, Hungary, Poland, Slovenia, Australia, Canada, France
Novartis Pharmaceuticals

Terminated

MS Study Evaluating Safety and Efficacy of Two Doses of Fingolimod Versus Copaxone (ASSESS)

Relapsing-remitting Multiple Sclerosis (RRMS)

United States, Canada, Mexico, Brazil, Puerto Rico, Argentina, Chile
Regeneron Pharmaceuticals

Recruiting

A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment (LINKER-MM4)

Multiple Myeloma

United States, France
Centre Hospitalier Universitaire de Nīmes

Completed

Evaluation of the Prevalence of Oculomotor Disorders in Patients With Radiologically Isolated Syndrome (OCRIS)

Multiple Sclerosis | Radiologically Isolated Syndrome (RIS)

France
Institut Paoli-Calmettes

Recruiting

Institut Paoli Calmettes Multiple Myeloma Database

Multiple Myeloma

France
Centre Hospitalier Universitaire de Nīmes
Centre Hospitalier Universitaire Dijon; Perpignan Hospital

Completed

Evaluation Study on Performance of Guided Clinical Pharmacy Consultation in Patients With Multiple Myeloma on First Oral Anticancer Treatment (CPS MYELOME)

Multiple Myeloma

France
University Hospital, Toulouse
Sanofi; Institut National de la Santé Et de la Recherche Médicale, France; Ta...

Recruiting

Follow-up of Patients With Multiple Myeloma in the West-Occitanie Region "Living With a Myeloma in West-Occitanie" (VAMOS)

Multiple Myeloma

France
Centre Hospitalier Henri Duffaut - Avignon
Institut de Formation en Ostéopathie du Grand Avignon

Terminated

Heart Rate Variability, Vagus Nerve and Cancer

Multiple Myeloma | Colorectal Cancer | Lung Cancer | Non Hodgkin Lymphoma

France
Hospices Civils de Lyon

Completed

Multiparametric Magnetic Resonance Imaging (MRI) in Medullary Sponge Kidney (MICARI)

Medullary Sponge Kidney

France
Nantes University Hospital

Withdrawn

Relevance Evaluation of [68Ga]Ga-PentixaFor for Initial Staging and Detection of Minimal Residual Disease in Multiple Myeloma Patients. (PENTI-MIDAS)

Multiple Myeloma

France
Assistance Publique - Hôpitaux de Paris

Unknown

Vertebral Fat Quantitative MRI as a Marker of Bone Fragility in Multiple Myeloma (MYELOMEFRAGIQUANTI)

Multiple Myeloma | Vertebral Fracture

France
CHU de Reims

Completed

ADPKD and Peritoneal Dialysis: How Anticipate Peritoneal Pressure? (PDP-ADPKD)

Autosomal Dominant Polycystic Kidney Disease

France
Pierre and Marie Curie University

Completed

Reproductibility of Cystometry in Multiple Sclerosis Patient

Multiple Sclerosis | Overactive Bladder | Lower Urinary Tract Symptoms | Overactive Detrusor | Cystometry

France

Clinical Trials on Multiple Osteochondroma in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations